# Vesselon, Inc.: Form D filings

Vesselon, Inc., a biotechnology company in Norwalk, CT, filed 5 Form D notices with the SEC between 2014 and 2016. The latest, on August 22, 2016, reports $250,000 sold of a $1 million offering to 3 investors.

Find out what Vesselon, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vesselon%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vesselon%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvesselon-inc-1613009)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vesselon%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vesselon%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvesselon-inc-1613009)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut): 428 rows, by operating companies, filed since November 1, 2024, $21.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/connecticut
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 101 Merritt 7, Suite 300, Norwalk, CT, 06851
- Phone: (203) 989-0500
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1613009

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 22, 2016 | Amendment | $1,000,000 | $250,000 | $750,000 | 3 | Mar 17, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613009/000161300916000004/0001613009-16-000004-index.htm) |
| Jul 5, 2016 | New notice | $150,000 | $75,000 | $75,000 | 1 | Jun 6, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613009/000161300916000003/0001613009-16-000003-index.htm) |
| Jul 5, 2016 | New notice | $150,000 | $150,000 | $0 | 1 | Mar 17, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613009/000161300916000002/0001613009-16-000002-index.htm) |
| Jun 11, 2015 | New notice | $4,000,000 | $1,000,000 | $3,000,000 | 11 | May 29, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613009/000161300915000001/0001613009-15-000001-index.htm) |
| Jul 18, 2014 | New notice | $200,000 | $100,000 | $100,000 | 1 | May 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613009/000161300914000001/0001613009-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Rhodemann Li | Executive Officer, Director |  |
| Jon Serbousek | Director |  |
| Paul Latchford | Director |  |
| Jurgen Raths | Director |  |
| Clay Larsen | Executive Officer, Director |  |

## Other biotechnology companies in Connecticut that filed recently

- [Allyx Therapeutics, Inc.](https://specstream.ai/data/form-d/company/allyx-therapeutics-inc-1865257) $27.9 million · Oct 21, 2026
- [Cloverleaf Bio, Inc.](https://specstream.ai/data/form-d/company/cloverleaf-bio-inc-2153574) $14.8 million · Sep 9, 2026

[Every Form D from the week of Aug 22, 2016](https://specstream.ai/data/form-d/week/2016-08-22) · [All recent filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Vesselon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).